New strategy could unlock the full potential of PROTAC medicines
Genetic Engineering & Biotechnology News (GEN) - 07-Jul-2026Researchers say protein-degrading drugs need a new development approach
Join the club for FREE to access the whole archive and other member benefits.
International Marketing Associate Director, Laboratory Testing Division, WuXi AppTec
At WuXi AppTec, Shanghao spearheads dynamic marketing initiatives for DMPK studies, enhancing brand visibility and augmenting lead generation within the drug development landscape. His role involves harmonizing efforts across DMPK, Bioanalysis, and Toxicology teams to market comprehensive solutions from IND-enabling studies to submission documentation, ensuring our clients experience streamlined drug development processes.
Shanghao's analytical prowess in assessing market trends fortifies our strategic positioning, allowing them to swiftly adapt to shifts in competitive landscapes, regulatory frameworks, and customer inclinations. This anticipatory approach, coupled with his PhD in Chemistry and proficiency in transmission electron microscopy, underpins his ability to foster innovation and elevate WuXi AppTec's offerings in the life sciences sector.
Visit website: https://cellculturedish.com/experts/shanghao-li/
Details last updated 04-Aug-2026
Researchers say protein-degrading drugs need a new development approach